MC

472.25

-0.95%↓

SANES

10.206

-1.41%↓

SAF

270.3

-3.57%↓

BBVA

18.525

-1.02%↓

BNP

88.96

-1.65%↓

MC

472.25

-0.95%↓

SANES

10.206

-1.41%↓

SAF

270.3

-3.57%↓

BBVA

18.525

-1.02%↓

BNP

88.96

-1.65%↓

MC

472.25

-0.95%↓

SANES

10.206

-1.41%↓

SAF

270.3

-3.57%↓

BBVA

18.525

-1.02%↓

BNP

88.96

-1.65%↓

MC

472.25

-0.95%↓

SANES

10.206

-1.41%↓

SAF

270.3

-3.57%↓

BBVA

18.525

-1.02%↓

BNP

88.96

-1.65%↓

MC

472.25

-0.95%↓

SANES

10.206

-1.41%↓

SAF

270.3

-3.57%↓

BBVA

18.525

-1.02%↓

BNP

88.96

-1.65%↓

Search

BRANICS Group AG

Geschlossen

1.4 -4.11

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.4

Max

1.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

-108M

-116M

Verkäufe

-1.5M

52M

EPS

-1.36

Gewinnspanne

-224.017

Angestellte

310

EBITDA

943K

33M

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

334M

Vorheriger Eröffnungskurs

5.51

Vorheriger Schlusskurs

1.4

BRANICS Group AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Apr. 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26. Apr. 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Major Central Bank -2-

24. Apr. 2026, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek Group Rejects EQT's Revised Offer

26. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26. Apr. 2026, 23:44 UTC

Ergebnisse

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26. Apr. 2026, 23:44 UTC

Ergebnisse

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26. Apr. 2026, 23:36 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Falls Amid Dollar's Strength -- Market Talk

26. Apr. 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24. Apr. 2026, 23:37 UTC

Akquisitionen, Fusionen, Übernahmen

Scoring the Cook Era -- Barrons.com

24. Apr. 2026, 20:51 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Financial Services Roundup: Market Talk

24. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. Apr. 2026, 20:39 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 20:09 UTC

Ergebnisse

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24. Apr. 2026, 19:48 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24. Apr. 2026, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24. Apr. 2026, 19:22 UTC

Ergebnisse

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24. Apr. 2026, 19:06 UTC

Ergebnisse

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24. Apr. 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24. Apr. 2026, 18:30 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24. Apr. 2026, 18:28 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek Rejects Revised EQT Offer

24. Apr. 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24. Apr. 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24. Apr. 2026, 17:42 UTC

Ergebnisse

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24. Apr. 2026, 17:28 UTC

Ergebnisse

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Peer-Vergleich

Kursveränderung

BRANICS Group AG Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über BRANICS Group AG

Branicks Group AG (formerly DIC Asset AG) is Germany's leading listed specialist for office and logistics real estate with 25 years of experience on the real estate market and with access to a broad-based network of investors. Our business is based on a regional and inter-regional real estate platform with nine offices on the ground in all major German markets (with VIB Vermögen AG included). We currently manage a total of 358 assets with a combined market value of EUR 14.2 billion on site, always close to our properties and their occupiers. The Commercial Portfolio segment comprises real estate held for our own account. Here, we generate steady cash flows from stable rent revenues on long-term leases while also optimising the value of our portfolio assets through active management, and realising gains from sales. In the Institutional Business segment, we earn recurrent fees from real estate services we provide to national and international institutional investors by structuring and managing investment products that return attractive dividend yields.
help-icon Live chat